Putative CSCs have been identified in pancreatic cancer based on the expression of the three surface markers CD44, CD24, and epithelial specific antigen (ESA) [26,27,28,29,30,31,32,33]. This evidence concerns the gene CD24 and pancreatic neoplasm.